Found: 102
Select item for more details and to access through your institution.
Continuous measurement of interstitial glycaemia in professional female UCI world tour cyclists undertaking a 9‐day cycle training camp.
- Published in:
- European Journal of Sport Science, 2024, v. 24, n. 11, p. 1573, doi. 10.1002/ejsc.12201
- By:
- Publication type:
- Article
Type 1 diabetes and physical activity: An assessment of knowledge and needs in healthcare practitioners.
- Published in:
- Journal of Diabetes Nursing, 2016, v. 20, n. 8, p. 271
- By:
- Publication type:
- Article
Association studies between the HSD11B2 gene (encoding human 11&bgr;-hydroxysteroid dehydrogenase type 2), type 1 diabetes mellitus and diabetic nephropathy.
- Published in:
- European Journal of Endocrinology, 2002, v. 146, n. 4, p. 553
- By:
- Publication type:
- Article
Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01106-4
- By:
- Publication type:
- Article
Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0871-8
- By:
- Publication type:
- Article
Comparative Effectiveness of Long-Acting GLP-1 Receptor Agonists in Type 2 Diabetes: A Short Review on the Emerging Data.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2020, v. 13, p. 433, doi. 10.2147/DMSO.S193693
- By:
- Publication type:
- Article
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2010, v. 3, p. 165
- By:
- Publication type:
- Article
EXPERIMENTAL AGENTS IN TYPE 2 DIABETES: THE NEXT 20 YEARS.
- Published in:
- West London Medical Journal, 2010, v. 2, n. 3, p. 29
- By:
- Publication type:
- Article
INCRETIN THERAPEUTICS IN DIABETES: 1902 TO PRESENT.
- Published in:
- West London Medical Journal, 2010, v. 2, n. 2, p. 15
- By:
- Publication type:
- Article
Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Genetics of diabetic nephropathy and microalbuminuria.
- Published in:
- Journal of the Royal Society of Medicine, 2000, v. 93, n. 2, p. 62, doi. 10.1177/014107680009300204
- By:
- Publication type:
- Article
Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01949-7
- By:
- Publication type:
- Article
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial.
- Published in:
- Diabetologia, 2024, v. 67, n. 9, p. 1783, doi. 10.1007/s00125-024-06142-3
- By:
- Publication type:
- Article
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial.
- Published in:
- Diabetologia, 2024, v. 67, n. 9, p. 1800, doi. 10.1007/s00125-024-06133-4
- By:
- Publication type:
- Article
Glucagon-like Peptide-1 Receptor Analogues for the Treatment of Obesity.
- Published in:
- touchREVIEWS in Endocrinology, 2022, v. 18, n. 1, p. 43, doi. 10.17925/ee.2022.18.1.43
- By:
- Publication type:
- Article
Changes in Plasma Levels of N-Arachidonoyl Ethanolamine and N-Palmitoylethanolamine following Bariatric Surgery in Morbidly Obese Females with Impaired Glucose Homeostasis.
- Published in:
- Journal of Diabetes Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/680867
- By:
- Publication type:
- Article
Ageing well with diabetes: A workshop to co‐design research recommendations for improving the diabetes care of older people.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 7, p. 1, doi. 10.1111/dme.14795
- By:
- Publication type:
- Article
Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 4, p. 1, doi. 10.1111/dme.14769
- By:
- Publication type:
- Article
Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: A population-based observational retrospective cohort study.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 3, p. 1, doi. 10.1111/dme.14697
- By:
- Publication type:
- Article
A woman with poorly controlled type 1 diabetes and pruritic papules on her buttocks.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Association of British Clinical Diabetologists and Renal Association guidelines on the detection and management of diabetes post solid organ transplantation.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 6, p. 1, doi. 10.1111/dme.14523
- By:
- Publication type:
- Article
Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: A national retrospective observational cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2243, doi. 10.1111/dom.15102
- By:
- Publication type:
- Article
Metabolic and physiological responses to graded exercise testing in individuals with type 1 diabetes using insulin pump therapy.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 878, doi. 10.1111/dom.14938
- By:
- Publication type:
- Article
The challenges and pitfalls of incorporating evidence from cardiovascular outcomes trials in health economic modelling of type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 639, doi. 10.1111/dom.14917
- By:
- Publication type:
- Article
Recent developments in GLP‐1RA therapy: A review of the latest evidence of efficacy and safety and differences within the class.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 30, doi. 10.1111/dom.14487
- By:
- Publication type:
- Article
Recent developments in GLP‐1RA therapy: A review of the latest evidence of efficacy and safety and differences within the class.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 30, doi. 10.1111/dom.14487
- By:
- Publication type:
- Article
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2487, doi. 10.1111/dom.14160
- By:
- Publication type:
- Article
Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2193, doi. 10.1111/dom.14140
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes by baseline albuminuria status and renal function: Results from the LEADER randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2077, doi. 10.1111/dom.14126
- By:
- Publication type:
- Article
The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1690, doi. 10.1111/dom.14079
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 3.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 1, doi. 10.1111/dom.14000
- By:
- Publication type:
- Article
Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 442, doi. 10.1111/dom.13955
- By:
- Publication type:
- Article
Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 303, doi. 10.1111/dom.13896
- By:
- Publication type:
- Article
Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2505, doi. 10.1111/dom.13835
- By:
- Publication type:
- Article
Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2450, doi. 10.1111/dom.13826
- By:
- Publication type:
- Article
Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1745, doi. 10.1111/dom.13698
- By:
- Publication type:
- Article
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 499, doi. 10.1111/dom.13553
- By:
- Publication type:
- Article
Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 611, doi. 10.1111/dom.13564
- By:
- Publication type:
- Article
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 454, doi. 10.1111/dom.13538
- By:
- Publication type:
- Article
A case series of DKA occurring in patients receiving treatment with SGLT‐2 inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 889, doi. 10.1111/dom.13172
- By:
- Publication type:
- Article
New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice.
- Published in:
- Drugs, 2022, v. 82, n. 2, p. 97, doi. 10.1007/s40265-021-01655-2
- By:
- Publication type:
- Article
Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors.
- Published in:
- Drugs, 2021, v. 81, n. 11, p. 1243, doi. 10.1007/s40265-021-01538-6
- By:
- Publication type:
- Article
Metabolic Implications when Employing Heavy Pre- and Post-Exercise Rapid-Acting Insulin Reductions to Prevent Hypoglycaemia in Type 1 Diabetes Patients: A Randomised Clinical Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097143
- By:
- Publication type:
- Article
The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 6, p. 895, doi. 10.1007/s10198-022-01514-1
- By:
- Publication type:
- Article
Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome.
- Published in:
- BMC Research Notes, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1756-0500-7-42
- By:
- Publication type:
- Article
Cost-effective strategies in the prevention of diabetic nephropathy.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond.
- Published in:
- Endocrinology & Metabolism, 2023, v. 38, n. 1, p. 25, doi. 10.3803/EnM.2022.1642
- By:
- Publication type:
- Article
A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment.
- Published in:
- Drug Design, Development & Therapy, 2013, v. 7, p. 893, doi. 10.2147/DDDT.S32331
- By:
- Publication type:
- Article